15.3 C
New York
Friday, September 29, 2023

Selecta Biosciences Inc. (NASDAQ: SELB) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Selecta Biosciences Inc. (SELB) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $1.23. The Selecta Biosciences Inc. has recorded 9,816 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $1.23 and fluctuated between $1.2699 as its day high and $1.2150 as its day low. The current market capitalization of Selecta Biosciences Inc. is $188.69M. A total of 0.77 million shares were traded on the day, compared to an average of 1.02M shares.

Insider Activity

Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, SELB has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 5 BUYs and 22 SELLs from insiders. Insiders purchased 693,738 shares during that period but sold 218,496.

In the most recent transaction, Brunn Carsten sold 13,473 shares of SELB for 1.13 per share on Jan 05. After the transaction, the President and CEO now owns 786,013 company shares. In a previous transaction on Jan 05, TRABER PETER G sold 3,465 shares at 1.13 per share. SELB shares that Chief Medical Officer owns now total 446,121.

Among the insiders who sold shares, Kishimoto Takashi Kei disposed of 3,392 shares on Jan 05 at a per-share price of $1.13. This resulted in the Chief Scientific Officer holding 364,316 shares of SELB after the transaction. In another insider transaction, Johnston Lloyd P. sold 3,392 shares at $1.13 per share on Jan 05. Company shares held by the Chief Operations Officer now total 265,515.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for SELB in the last 3 months, the mean price target is $3.50 with high estimates of $5.00 and low estimates of $1.00. In terms of 52-week highs and lows, SELB has a high of $1.99 and a low of $0.90.

As of this writing, SELB has an earnings estimate of -$0.06 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of $0.04 per share and a lower estimate of -$0.1. The company reported an EPS of -$0.14 in the last quarter, which was -55.60% lower than expectations of -$0.09.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SELB’s latest balance sheet shows that the firm has $128.06M in Cash & Short Term Investments as of fiscal 2021. There were $35.28M in debt and $72.25M in liabilities at the time. Its Book Value Per Share was $0.43, while its Total Shareholder’s Equity was $22.52M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SELB is Buy with a score of 4.50.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles